Technical Assessment Signals Bullish IntermediateTerm Outlook for Equities Dell Technologies Leads AI Server Rally with 15 Surge HPE and Super Micro Also Advance on AI Capex Momentum Family Travel Boom Exclusive Ranch and Lodge Lead AllInclusive Resort Trends Prediction Markets Face Legal Clash as State and Federal Regulators Diverge Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment Lynas Rare Earth Deal with Pentagon Sparks Controversy in Malaysia Revelation Biosciences Q1 2026 Earnings EPS Miss Highlights Ongoing PreRevenue Stage Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Over 40 Yet Stock Rises Liberty Latin America Ltd LILAK Q1 2026 Earnings EPS Misses Estimates Sharply Despite Strong Stock Rally PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress Pliant Therapeutics PLRX Holds Near Support Amid Modest Gains Key Levels in Focus AO Smith AOS Holds Near Support After Modest Decline Harvard Ave Acquisition Corporation Unit HAVAU Holds Steady at 1028 Amid Limited Trading Activity John Hancock Financial Opportunities Fund BTO Edges Lower as Financial Sector Faces Mixed Signals Capital One Financial COF Holds Steady Near Resistance as Volume Signals Caution ICE Q1 2026 Earnings Earnings Beat Estimates on 29 Surprise Shares Edge Higher SM Q1 2026 Earnings EPS Surges Past Estimates by 317 but Stock Declines PermaFix Environmental Services PESI Q1 2026 Earnings Significant EPS Miss Amid No Reported Revenue IBP Q1 2026 Earnings Earnings Miss Amid Sustained Operational Headwinds XPEV Q4 2025 Earnings A Stunning Profit Beat Drives Shares Higher CARE Q1 2026 Earnings EPS Misses Estimates by Over 85 as Stock Rises Samsung Chip Workers to Receive Average Bonus of 432000 Under Tentative Strike Deal Garmin Q1 2026 Earnings EPS Beats Estimates by 12 Shares Edge Higher Inhibrx Biosciences INBX Surges Over 5 as Biotech Momentum Builds